Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-008983
Filing Date
2023-08-17
Accepted
2023-08-17 11:30:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27650
2 filename2.txt TEXT-EXTRACT 1494
  Complete submission text file 0000000000-23-008983.txt   40398
Mailing Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017
Business Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017 (646) 677-3870
Actinium Pharmaceuticals, Inc. (Filed for) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-273911
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)